Lloyd Miller, J&J Innovative Medicine, On the Need for Diversity in Immunology Clinical Trials

Lloyd Miller, J&J Innovative Medicine, On the Need for Diversity in Immunology Clinical TrialsПодробнее

Clinical Trials Awareness Week 2022Подробнее

Diversity in Clinical TrialsПодробнее

Clinical Trials Awareness Week - A Patient's PerspectiveПодробнее

Clinical Trials Awareness MonthПодробнее

Reshaping the Future of ImmunologyПодробнее

We are Johnson & Johnson Innovative MedicineПодробнее

Clinical Trials Awareness Week 2022Подробнее

Why is Diversity Important in Clinical Trials?Подробнее

The Evolution of Diverse Representation in Clinical TrialsПодробнее

Janssen DiseaseLens™Подробнее

Dr. Jun LiПодробнее

It's Not Science Fiction, It's Leading Where Medicine is GoingПодробнее

The History of the Department of Genetic MedicineПодробнее

3 Reasons People Join a Clinical TrialПодробнее

Dr Georges Benjamin: Healthcare Diversity Has to Start at the Very TopПодробнее

Janssen 4 Patients - Because knowledge mattersПодробнее

Gene identification in congenital immune diseases lead to precision medicine therapiesПодробнее

Empowering health care providers in the era of personalized medicineПодробнее

GM5: A Genomic Medicine Policy Framework - Debora LeonardПодробнее